156TiP Impact of neoadjuvant immunotherapy in early stage breast cancer before standard therapy (BIS-Program)
Autor: | Ribeiro, J.T.M.L.M., Rassy, E., Salabert, L., Viansone, A.A., Parpaleix, A., Blanc, A.S., Mahout, I., Laghouati, S., Mouret Reynier, M.A., Petit, T., André, F., Michiels, S., Dalenc, F., Pistilli, B., Arnedos, M. |
---|---|
Zdroj: | In ESMO Open May 2023 8(1) Supplement 4 |
Databáze: | ScienceDirect |
Externí odkaz: |